Jan 10, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2022-D-0697-0006
Association for Accessible Medicines Comment Letter
FDANonrulemakingFDA-2022-D-0697
Sameness Evaluations in an Abbreviated New Drug Application – Active Ingredients; Draft Guidance for Industry; Availability
RIN
—
Last modified
Jan 10, 2023
Comment window
closed 1296d ago
Association for Accessible Medicines filings
1
Activity
Association for Accessible Medicines filed 1 comment on this docket between Jan 10, 2023 and Jan 10, 2023. 0 other organizations filed here. The comment window closed 1296d ago.
What Association for Accessible Medicines filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (0)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG1 filing · confidence 97%